Japan, March 23 -- AURIGENE ONCOLOGY LTD has got intellectual property rights for 'METHOD OF MODULATING TIGIT AND PD-1 SIGNALLING PATHWAYS USING 1,2,4-OXADIAZOLE COMPOUNDS.' Other related details are as follows:

Application Number: JP,2023-202431

Category (FI): A61K31/4245,A61P1/02,A61P1/04,A61P1/16,A61P1/18,A61P11/00,A61P11/02,A61P11/04,A61P13/02,A61P13/08,A61P13/10,A61P13/12,A61P15/00,A61P15/02,A61P17/00,A61P19/08,A61P25/00,A61P29/00,A61P31/00,A61P31/04,A61P31/10,A61P31/12,A61P33/00,A61P35/00,A61P35/02,A61P35/04,A61P37/02,A61P37/04,A61P37/06,A61P43/00,105,A61P43/00,111,A61P5/00,A61P5/14,A61P5/18,A61P5/38,A61P7/10,A61P9/00

Stage: Grant (IP right document published.)

Filing Date: Nov. 30, 2023

Publication Date: Feb. 28, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.